Effects of imidacloprid metabolites on habituation in honeybees suggest the existence of two subtypes of nicotinic receptors differentially expressed during adult development.
Habituation of the proboscis extension reflex (PER) in honeybees (Apis mellifera) is age-dependent. Very young bees (< or =7 days old) require significantly less trials to abolish the response to multiple sucrose stimulations than older bees (> or =8 days old). A nicotinic agonist, imidacloprid, modifies this behaviour by increasing the number of trials in < or =7-day-old bees and by decreasing it in older bees [Neurobiol. Learn. Mem. 76 (2001) 183.]. Here we tested our hypothesis that this effect is associated with a differential expression of two subtypes of nicotinic acetylcholine receptors (nAChRs). By testing the effects of six metabolites of imidacloprid, we show that two of them, olefin and 5-hydroxy-imidacloprid, modify the number of trials needed to habituate the PER in a contrasting manner. Olefin increases the number of trials in both age groups, whereas 5-hydroxy-imidacloprid decreases the number of trials, but only in 8-day-old individuals. We conclude that olefin and 5-hydroxy-imidacloprid are specific agonists of two subtypes of an nAChR that are differentially expressed during adult maturation of young honeybees. Olefin is the agonist of an nAChR expressed in both age groups, whereas 5-hydroxy-imidacloprid is the agonist of a late-onset nAChR that is activated in 8-day-old bees. The implications of this finding for the honeybee biology are discussed.
Guez
D
D
Visual Sciences, Research School of Biological Sciences, Australian National University, Canberra, ACT 0200, Australia. guez@rsbs.anu.edu.au
Belzunces
L P
LP
Maleszka
R
R
D000375:Aging / Q000502:physiology; D000475:Alkenes / Q000494:pharmacology; D000818:Animals; D001516:Bees / Q000254:growth & development* / Q000502:physiology*; D001711:Biotransformation; D004305:Dose-Response Relationship, Drug; D006185:Habituation, Psychophysiologic / Q000187:drug effects*; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology*; D007858:Learning / Q000187:drug effects; D000073943:Neonicotinoids; D018722:Nicotinic Agonists / Q000493:pharmacokinetics / Q000494:pharmacology*; D009574:Nitro Compounds; D011978:Receptors, Nicotinic / Q000096:biosynthesis / Q000187:drug effects*
D000475:Alkenes; D007093:Imidazoles; D000073943:Neonicotinoids; D018722:Nicotinic Agonists; D009574:Nitro Compounds; D011978:Receptors, Nicotinic; C082359:imidacloprid